Therapeutic Targeting of Oxidative Phosphorylation in Microsatellite Instability-High Gastric Cancer

Bing Ang1, Yi Bai2, Xiyue Deng3

  • 1Department of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.

Journal of Cancer
|April 27, 2026
PubMed
Abstract

Insights

Gastric cancer subtypes with microsatellite instability (MSI) show increased oxidative phosphorylation metabolism. Five key genes involved in this pathway may offer new therapeutic targets for MSI gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • Gastric cancer is a major global health concern, ranking third in cancer mortality.
  • The Cancer Genome Atlas classifies gastric cancer into four subtypes, including microsatellite instability (MSI) and genomically stable (GS).
  • Metabolic reprogramming within the tumor microenvironment of these subtypes is not well understood.

Purpose of the Study:

  • To investigate the metabolic differences between MSI and GS gastric cancer subtypes.
  • To identify key genes and pathways involved in metabolic reprogramming in MSI gastric cancer.
  • To explore potential therapeutic targets for MSI gastric cancer.

Main Methods:

  • Single-cell RNA sequencing was used to analyze tumor samples from GS and MSI gastric cancer patients.
  • Differential gene expression and pathway analyses were performed on malignant epithelial cells.
  • LASSO regression identified key oxidative phosphorylation genes, validated in TCGA data and patient-derived xenograft models.

Main Results:

  • MSI tumors exhibited increased T cell infiltration and fewer epithelial cells compared to GS tumors.
  • Malignant cells in MSI samples showed heightened oxidative phosphorylation pathway activity.
  • Five oxidative phosphorylation genes were consistently upregulated in MSI tumors and associated with faster tumor growth and higher ATP levels.

Conclusions:

  • MSI gastric cancer demonstrates enhanced oxidative phosphorylation metabolism at the single-cell level.
  • Five specific oxidative phosphorylation-related genes are identified as potential therapeutic targets for MSI gastric cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K